Reducing the burden of serious mental illness through research
The Stanley Center aims to exploit the most advanced technologies for human genetic analysis to study psychiatric disorders in order to understand disease mechanisms, identify potential biomarkers, and ignite needed progress in therapeutics. However, the increasingly successful discovery of genetic variants associated with disease is only the beginning. Our goal is not to end with a list of genes, but to contribute to new understandings of pathogenesis, the identification of biomarkers, and above all, new treatments.
As a result, the Stanley Center has not divided itself into disease-specific intellectual silos. Rather we are organized into intellectually porous teams based on principal disciplinary areas of focus:
- Stem cell-based models
- Neurobiology and animal models
- Technology development and genome-scale neurobiology
- Clinical trials
We also collaborate extensively with research groups around the world to identify important patient populations, technologies, and scientific approaches that will significantly advance our research objectives and knowledge for the psychiatric research community.